Bioresource Technology Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bioresource Technology Inc. - overview
Established
1984
Location
-, FL, US
Primary Industry
Biotechnology
About
Based in Florida, US, and founded in 1984 by Dr. David Reichenbach, Bioresource Technology Inc. operates as a biotechnology company that offers base matrices and other critical raw materials for the IVD industry. In June 2022 Medix Biochemica acquired 100 percent of the shares of Bioresource Technology.
As of November 2022, the company has a team of 20 people. Bioresource Technology Inc. manufactures human AB serum which is used in tissue engineering, transplantation, and cell therapy applications for the expansion of mesenchymal stem cells; diagnostic base matrices; molecular diagnostics products; HDL and LDL cholesterol concentrates as well as triglycerides for use in the development and manufacture of IVD QC products, including controls, calibrators, standards, and proficiency tests.
Current Investors
Oy Medix Biochemica Ab
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Medicinal Chemicals & Botanicals
Website
www.brt-us.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Bioresource Technology Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Bioresource Technology Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.